Screener
Emergent Biosolutions EBS Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Emergent Biosolutions’s 10-Q, filed August 6, 2026.
- Filed
- Aug 5, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001367644-26-000082
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total other income (expense), net | (41.2) | (18.4) | (38.3) | 24.4 |
| Income (loss) before income taxes | (166.3) | (16.8) | (152.9) | 75.9 |
| Income tax provision (benefit) | 13.9 | (4.8) | 20.5 | 19.9 |
| Net income (loss) | $(180.2) | $(12.0) | $(173.4) | $56.0 |
| Earnings (loss) per common share | ||||
| Basic | $(3.49) | $(0.22) | $(3.35) | $1.03 |
| Diluted | $(3.49) | $(0.22) | $(3.35) | $0.99 |
| Weighted average shares outstanding |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Emergent Biosolutions's net income?
- Emergent Biosolutions (EBS) reported net income of -$180.2M in Q2 2026.
- How has Emergent Biosolutions's net income changed year-over-year?
- Emergent Biosolutions's net income decreased by 1401.7% year-over-year, from -$12M to -$180.2M.
- What is the long-term trend for Emergent Biosolutions's net income?
- Over 3 years (2021 to 2024), Emergent Biosolutions's net income has grown at a -4.6% compound annual growth rate (CAGR), from $219.5M to -$190.6M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Emergent Biosolutions's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude